diabetes treatment
Eli Lilly’s Foundayo Shows Promising Results for Type 2 Diabetes Management
Eli Lilly’s Foundayo shows promising results in managing Type 2 diabetes, emphasizing safety and efficacy in cardiometabolic health.
Indian Pharmaceutical Firms Launch Affordable Alternatives to Ozempic and Wegovy
Indian drugmakers are launching cheaper versions of Ozempic and Wegovy, enhancing treatment accessibility for diabetes and obesity management.
Torrent Pharma Launches India’s First Oral Semaglutide at ₹3,999/Month
Torrent Pharma has launched India’s first oral semaglutide, revolutionizing diabetes management with a convenient, affordable option.
Natco Introduces Semaglutide at Rs 1,290: A New Era for Diabetes Treatment
Natco Pharma launches semaglutide at Rs 1,290, aiming to make diabetes treatment more accessible and reshape the weight-loss drug market in India.